Skip to main content

TXG

10x Genomics, Inc.

Company with tickers: TXG

CIK
1770787
CUSIP
88025U109
Shares Outstanding
116,877,317
13F Activity (30d)
172 filings 165 filers

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue
Revenue (ASC 606)
Cost of Revenue
Gross Profit
Operating Expenses
Research & Development
Operating Income
Net Income
EPS (Basic)
EPS (Diluted)

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

By Geography (USD)

Component 2023-12-31 2024-12-31 2025-12-31
Americas $373,192,000 $347,765,000 $358,773,000
United States $360,091,000 $334,318,000 $346,512,000
EMEA $142,276,000 $159,762,000 $161,716,000
Asia Pacific $103,259,000 $103,258,000 $122,334,000
China $50,965,000 $57,300,000 $70,264,000
Asia Pacific Excluding China $52,294,000 $45,958,000 $52,070,000
Americas Excluding United States $13,101,000 $13,447,000 $12,261,000

By Product & Service (USD)

Component 2023-12-31 2024-12-31 2025-12-31
Product And Service Revenue $618,727,000 $610,464,000 $596,688,000
Consumables $479,553,000 $493,432,000 $507,183,000
Single Cell Consumables $420,316,000 $372,308,000 $363,206,000
Spatial Consumables $59,237,000 $121,124,000 $143,977,000
Instruments $123,471,000 $92,715,000 $56,779,000
Licensing And Royalty Revenue $0 $321,000 $46,135,000
Spatial Instruments $75,605,000 $57,503,000 $34,108,000
Service $15,703,000 $24,317,000 $32,726,000
Single Cell Instruments $47,866,000 $35,212,000 $22,671,000